These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 853505)

  • 41. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
    Blot N; Schneider P; Young P; Janvresse C; Dehesdin D; Tron P; Vannier JP
    Bone Marrow Transplant; 2000 Oct; 26(8):903-5. PubMed ID: 11081393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of phosphonoacetic acid in the treatment of experimental herpes simplex keratitis.
    Gordon YJ; Lahav M; Photiou S; Becker Y
    Br J Ophthalmol; 1977 Aug; 61(8):506-9. PubMed ID: 199232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antiviral activity of new indole-based heterocycles.
    Abdel-Gawad H; Mohamed HA; Dawood KM; Badria FA
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1529-31. PubMed ID: 21048349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NDA filed to treat refractory herpes.
    AIDS Patient Care STDS; 1997 Apr; 11(2):103. PubMed ID: 11361756
    [No Abstract]   [Full Text] [Related]  

  • 47. [Inhibitory effect of various analogs of nucleoside-5'-triphosphates on DNA synthesis catalyzed by DNA polymerase from herpes simplex virus type I].
    Kilesso TIu; Shobukhov VM; Papchikhin AV; Galegov GA
    Mol Gen Mikrobiol Virusol; 1987 Oct; (10):41-4. PubMed ID: 2828934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antiviral activity of (S)-9-[4-hydroxy-3-(phosphonomethoxy)butyl]guanine.
    Kim CU; Luh BY; Martin JC
    J Med Chem; 1990 Jun; 33(6):1797-800. PubMed ID: 2160539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Herpes simplex virus infection: an overview of the problem, pharmacologic therapy and dietary measures].
    Hassan STS; Šudomová M; Masarčíková R
    Ceska Slov Farm; 2017; 66(3):95-102. PubMed ID: 28914066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disseminating herpes simplex infection: primary lesions in urinary bladder and successful treatment with forscarnet sodium.
    Blohmé I; Ahlmén J; Jeansson S; Ranch T; Brynger H
    Transplant Proc; 1984 Dec; 16(6):1672-4. PubMed ID: 6239431
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient.
    Kopp T; Geusau A; Rieger A; Stingl G
    Br J Dermatol; 2002 Jul; 147(1):134-8. PubMed ID: 12100196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1.
    Dávola ME; Mazaira GI; Galigniana MD; Alché LE; Ramírez JA; Barquero AA
    Antiviral Res; 2015 Oct; 122():55-63. PubMed ID: 26259812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.
    Zhou S; Breitenbach JM; Borysko KZ; Drach JC; Kern ER; Gullen E; Cheng YC; Zemlicka J
    J Med Chem; 2004 Jan; 47(3):566-75. PubMed ID: 14736238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel selective broad-spectrum anti-DNA virus agent.
    De Clercq E; Holý A; Rosenberg I; Sakuma T; Balzarini J; Maudgal PC
    Nature; 1986 Oct 2-8; 323(6087):464-7. PubMed ID: 3762696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and antiviral activity of phthiobuzone analogues.
    Yang YJ; Zhao JH; Pan XD; Zhang PC
    Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):208-11. PubMed ID: 20118580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological evaluation of1',2'-seconucleo-5'- phosphonates.
    Racha S; Vargeese C; Vemishetti P; El-Subbagh HI; Abushanab E; Panzica RP
    J Med Chem; 1996 Mar; 39(5):1130-5. PubMed ID: 8676349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
    Klein RJ
    Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
    Ahlmén J; Wijnween AC; Brynger H; Lycke E
    Scand J Urol Nephrol Suppl; 1985; 92():41-4. PubMed ID: 3008316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
    Knopf CW
    J Gen Virol; 1987 May; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.